Pathophysiological aspects of Sjögren's Syndrome: a narrative review




Pathophysiology; Semiology; Sjögren's syndrome.


Sjögren's Syndrome (SS) is a systemic autoimmune disease characterized by the involvement of exocrine glands, in addition to the presence of signs/symptoms of systemic disease. The lacrimal and salivary glands are often affected, causing sicca syndrome, characterized by dryness of the eyes (xerophthalmia) and mouth (xerostomia). This article aims to address a pathophysiological line of SS in a clinical context. This study is a narrative review with the purpose of discussing and describing the pathophysiology of SS in its clinical context. The following databases were used: SciElo (Scientific Electronic Library Online) and PubMed (US National Library of Medicine), with language restriction (Portuguese) and prioritizing articles published between 2010 and 2022. Mononuclear cell infiltration, humoral factors such as antibodies and cytokines, which are described in the literature as responsible for causing a structural and, consequently, functional alteration of the exocrine gland, causing a marked decrease in the production of tears by the lacrimal glands and a decrease in the production of saliva by the salivary glands. In short, SS remains a significant burden on healthcare systems around the world. However, the advances made in understanding its pathophysiology in the last 20 years surpass everything that has gone before.


Angus D. C., et al (2001). Epidemiologia da sepse grave nos Estados Unidos: análise da incidência, resultado e Araújo, C. V de, et al (2021). Fisiopatologia da Síndrome de Sjögren e sua dificuldade diagnóstica. Research, Society and Development; 10: e41010716989–e41010716989.

Bayetto, K., & Logan, R. M. (2010). Sjögren’s syndrome: a review of aetiology, pathogenesis, diagnosis and management. Australian Dental Journal, 55 Suppl 1, 39–47.

Betim, F., et al (2015). Da Descoberta às Perpectivas da Síndrome de Sjögren: uma Revisão de Literatura. Revista Eletrônica Biociências, Biotecnologia e Saúde, Curitiba, 13, 20–31.

Cavalcante, W., et al (2017). Síndrome de Sjögren primária : aspectos relevantes para os dentistas. Clinical and Laboratorial Research in Dentistry, 1–11.

Cornec, D., et al. (2012). B cells in Sjögren’s syndrome: From pathophysiology to diagnosis and treatment. Journal of Autoimmunity, 39(3), 161–167.

Flament, T., et al (2016). Pulmonary manifestations of Sjögren’s syndrome. European Respiratory Review, 25(140), 110–123.

Gomes, R., et al (2010). Síndrome de Sjögren primária. Revista Da Sociedade Brasileira de Clínica Médica, 8(3), 254–265.

Hajiabbasi, A., et al (2016). Secondary sjogren’s syndrome in 83 patients with rheumatoid arthritis. Acta Medica Iranica, 54(7), 448–453.

Jonsson, R., et al (2018). Current concepts on Sjögren’s syndrome – classification criteria and biomarkers. European Journal of Oral Sciences, 126, 37–48.

Kollert, F., & Fisher, B. A. (2020). Equal rights in autoimmunity: Is Sjögren’s syndrome ever “secondary”? Rheumatology (United Kingdom), 59(6), 1218– 1225

Kyriakidis, N. C., et al. (2014). A comprehensive review of autoantibodies in primary Sjögren’s syndrome: Clinical phenotypes and regulatory mechanisms. Journal of Autoimmunity, 51, 67–74.

Lieberman, S. M. (2013). Childhood Sjögren syndrome: Insights from adults and animal models. Current Opinion in Rheumatology, 25(5), 651–657.

Molina, G., et al. (2011). The meaning of anti-Ro and anti-La antibodies in primary Sjögren’s syndrome. Autoimmunity Reviews, 10(3), 123–125.

Nisihara, R., et al. (2016). Anti-alpha-fodrin antibodies in patients with Sjögren’s syndrome secondary to rheumatoid arthritis. Jornal Brasileiro de Patologia e Medicina Laboratorial, 52(3), 137–141.

Pasoto, S. G., Martins, V. A. de O., & Bonfa, E. (2019). Sjögren’s syndrome and systemic lupus erythematosus: Links and risks. Open Access Rheumatology: Research and Reviews, 11, 33–45.

Pereira A. S. et al. (2018). Metodologia da pesquisa científica. UFSM.

Santos, A., et al. (2013). Síndrome de Sjögren. Journal of Biodentistry and Biomaterials - Universidade Ibirapuera São Paulo, 3, 47–54.

Stefanski, A. L., et al (2017). The diagnosis and treatment of Sjögren’s syndrome. Deutsches Arzteblatt International, 114(20).

Tsukamoto, M., Suzuki, K., & Takeuchi, T. (2018). Ten-year observation of patients with primary Sjögren’s syndrome: Initial presenting characteristics and the associated outcomes. International Journal of Rheumatic Diseases, 22(5), 929–933.

Zerón, P. B., & Casals, M. R. (2014). Advances in the understanding and treatment of systemic complications in Sjögren’s syndrome. Current Opinion in Rheumatology, 26(5), 520–527.

Zerón, P. B., et al (2016). Sjögren syndrome. Nature Reviews Disease Primers, 2, 1–20.



How to Cite

BATISTA, M. N. .; FERREIRA, G. R. .; COSTA , A. M. P. da .; MIRANDA , G. de D. .; LOPES, A. X. .; PEREIRA, T. I. .; RAMALHO , A. V. S. .; LOPES , B. X. .; MELO, R. V. .; DALMAGRO, M. E. T. . Pathophysiological aspects of Sjögren’s Syndrome: a narrative review. Research, Society and Development, [S. l.], v. 12, n. 4, p. e8512441010, 2023. DOI: 10.33448/rsd-v12i4.41010. Disponível em: Acesso em: 27 sep. 2023.



Health Sciences